NCT00313313 A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas Status COMPLETED Phase PHASE3
NCT00295633 A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone Status COMPLETED Phase PHASE3
NCT00286442 Efficacy and Safety of Alogliptin Combined With Metformin in Participants With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT00283816 Impact of Metformin in Teens With Polycystic Ovary Syndrome (PCOS) on Oral Contraceptive Therapy Status COMPLETED Phase PHASE3
NCT00282945 Beta Cell Function Tests Over Time In Patients With T2dm Randomized To Metformin Or Rosiglitazone Status TERMINATED Phase NA
NCT00279240 Life Style Modifications Prevents Type 2 Diabetes in Asian Indians Status COMPLETED Phase PHASE1
NCT00279045 Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide Status COMPLETED Phase PHASE3
NCT00272064 ELEONOR STUDY: Insulin Glulisine in Type 2 Diabetes Mellitus. Status COMPLETED Phase PHASE3
NCT00268476 Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT00266253 A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin Status COMPLETED Phase PHASE2
NCT00265746 Prevention of Diabetes Mellitus Development in Women Who Had Already Experienced A Gestational Diabetes Status WITHDRAWN Phase PHASE4
NCT00263965 ARAMIS: Actions of tesaglitazaR on fAt Metabolism and Insulin Sensitivity Status TERMINATED Phase PHASE2
NCT00263276 A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT00247117 Metformin in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD) Status UNKNOWN Phase NA
NCT00191464 Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postprandial Glycemic Control of Patients With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT00187720 Genetic Basis for Variation in the Renal Elimination of Metformin Status COMPLETED Phase PHASE4